Robex Obtains Final Court Approval for Plan of Arrangement

(TSX-V:RBX),(AUST:RXR.AU),(AUST:RXR.XA),(Pinksheets:RSRBF),(PinkSheets:RSRBF),(Boerse Frankfurt – Freiverkehr:RB4),(AUST:RXR.AX), QUÉBEC CITY, Jan. 13, 2026 (GLOBE NEWSWIRE) — Robex Resources Inc. (“Robex” or the “Company“) is pleased to announce it has obtained a final order from the Quebec Superior Court (Commercial Division) approving the previously announced merger with Predictive Discovery Limited (“Predictive“) pursuant to which Predictive, through its direct wholly-owned subsidiary, […]

Robex Obtains Final Court Approval for Plan of Arrangement

Robex Obtains Final Court Approval for Plan of Arrangement GlobeNewswire January 13, 2026 QUÉBEC CITY, Jan. 13, 2026 (GLOBE NEWSWIRE) — Robex Resources Inc. (“Robex” or the “Company“) is pleased to announce it has obtained a final order from the Quebec Superior Court (Commercial Division) approving the previously announced merger with Predictive Discovery Limited (“Predictive“)

Macrophage Activation Syndrome Market in the 6MM to Witness Upsurge in Growth at a CAGR of 24.7% During the Forecast Period (2025-2034) | DelveInsight

The macrophage activation syndrome market is experiencing steady growth, driven by broadened treatment options, improved survival outcomes, and the launch of emerging therapies such as targeting SIRP-a/B1/ (ELA026), targeting Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) (Plonmarlimab), IL-18 inhibitor (Tadekinig alfa), dual IL-1B and IL-18 inhibitor (MAS825), and others. DelveInsight’s Macrophage Activation Syndrome Market Insights report includes a

Builders Capital Mortgage Corp Announces Third Closing of Bond Offering

Calgary, Alberta–(Newsfile Corp. – January 13, 2026) – Builders Capital Mortgage Corp. (TSXV: BCF) (“Builders Capital” or “the Company“) had previously announced its intention to proceed with a participating bond offering (the “Bonds“) to raise gross proceeds of up to $50 million closing in one or more tranches (the “Offering“), the details of which are

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of StubHub

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In StubHub To Contact Him Directly To Discuss Their Options If you purchased or otherwise acquired stock of StubHub pursuant and/or traceable to StubHub’s registration statement for the initial public offering held on or about September 17, 2025 and would

Probe Gold Announces Receipt of Shareholder Approval for Proposed Plan of Arrangement with Fresnillo

(TSX:PRB),(OTC US:PROBF),(Other OTC:PROBF), TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) — Probe Gold Inc. (“Probe” or the “Company”) (TSX: PRB) (OTCQB: PROBF) is pleased to announce that at the special meeting of Probe's shareholders (the “Shareholders“) held on January 13, 2026 (the “Meeting“), the shareholders voted in favour of the special resolution (the “Arrangement Resolution“), approving

Probe Gold Announces Receipt of Shareholder Approval for Proposed Plan of Arrangement with Fresnillo

Probe Gold Announces Receipt of Shareholder Approval for Proposed Plan of Arrangement with Fresnillo GlobeNewswire January 13, 2026 TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) — Probe Gold Inc. (“Probe” or the “Company”) (TSX: PRB) (OTCQB: PROBF) is pleased to announce that at the special meeting of Probe's shareholders (the “Shareholders“) held on January 13, 2026

Global Loaners Launches Jewelry-Backed Line of Credit Loans

Photo Courtesy of Global Loaners Summary: A Virginia fintech company reports the launch of a digital collateral appraisal system for jewelry-secured credit lines, regulated under state pawnbroker licensing. RICHMOND, Va., Jan. 13, 2026 (GLOBE NEWSWIRE) — Global Loaners, a Virginia-licensed pawn service provider, has announced the expansion of its digital platform for collateral-based lending. The

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses in Aquestive Therapeutics to Contact Him Directly to Discuss Their Options If you suffered significant losses in Aquestive Therapeutics stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at

Scroll to Top